{"text": "rt AT_USER been opining on this for almost 2 yrs now. patient access, patient access, patient access. $gild $juno $nvs URL"}
{"text": "was away for the day attending a conference, wtf did you guys do? $gild $cmg"}
{"text": "$gild: gilead sciences exec chairman john martin, phd will transition to chairman effective march 9, 2018 URL"}
{"text": "big call buyers URL $wday $lnce $slb $wfc $gild $adi $pbr $swn $cmcsa $pfe $txn $amrn $al $sbux $espr $ups $gef $vrx"}
{"text": "rt AT_USER galapagos exercises co-promotion option for filgotinib with collaboration partner gilead sciences in eight european cou\u00a1\u00ad"}
{"text": "galapagos exercises co-promotion option for filgotinib with collaboration partner gilead sciences in eight european\u00a1\u00ad URL"}
{"text": "don't miss our next free option trade.  sign up for our daily free trades at URL $nvda $tsla $gs $gild $biib $googl $fb"}
{"text": "#options #maxpain chart for $gild. free options app URL URL"}
{"text": "$gild makes strategic move URL"}
{"text": "rt AT_USER perils of first: $gild's yescarta can save the lives of lymphoma patients. we talked to everyone authorized to give it. only\u00a1\u00ad"}
{"text": "AT_USER AT_USER nope, not from $gild (perhaps they would have been allowed to if someone else would have done\u00a1\u00ad URL"}
{"text": "rt AT_USER the difference, btw, is that executive chairman is more of an active day-to-day role. $gild"}
{"text": "rt AT_USER $gild john martin further easing his way out of day-to-day operations. URL"}
{"text": "rt AT_USER $gild announces that john c. martin, phd will transition from executive chairman to chairman of the bod  URL"}
{"text": "$gild john martin further easing his way out of day-to-day operations. URL"}
{"text": "rt AT_USER $gild announces that john c. martin, phd will transition from executive chairman to chairman of the bod  URL"}
{"text": "$gild announces that john c. martin, phd will transition from executive chairman to chairman of the bod  URL"}
{"text": "p-a-w capital has boosted its gilead sciences $gild holding URL"}
{"text": "the difference, btw, is that executive chairman is more of an active day-to-day role. $gild"}
{"text": "galapagos elects to co-promote filgotinib with gilead in europe $glpg $gild  lockup and standstill agreement betwee\u00a1\u00ad URL"}
{"text": "$gild gilead sciences announces that john c. martin, phd will transition from executive chairman to chairm... - URL"}
{"text": "$gild john martin will transition from executive chairman to chairman. this might be a good candidate for AT_USER URL"}
{"text": "rt AT_USER $glpg exercises co-promotion option for filgotinib with collaboration partner $gild  in eight european countries URL"}
{"text": "$gild - gilead sciences announces that john c. martin, phd will transition from executive chairman to chairman URL"}
{"text": "$glpg exercises co-promotion option for filgotinib with collaboration partner $gild  in eight european countries URL"}
{"text": "rt AT_USER $glpg exercises co-promotion option for filgotinib with collaboration partner $gild  in eight european countries URL"}
{"text": "rt AT_USER $glpg exercises co-promotion option for filgotinib with collaboration partner $gild  in eight european countries URL"}
{"text": "galapagos elects to co-promote filgotinib with gilead in europe URL $glpg $gild"}
{"text": "galapagos elects to co-promote filgotinib with gilead in europe URL $glpg $gild"}
{"text": "ardsley advisory partners has trimmed gilead sciences $call $gild holding by $3.50 million ..."}
{"text": "AT_USER AT_USER which would of course render the co-promotion agreement futile :) $glpg $gild"}
{"text": "AT_USER AT_USER yes, that's great news as well. takeover on jan 1, 2018 please. at $250 per $glpg share. $gild"}
{"text": "AT_USER its interesting $glpg announces when the standstill with $gild ends (12/31/17) too."}
{"text": "AT_USER great news!!! $glpg $gild #filgotinib"}
{"text": "rt AT_USER $glpg exercises co-promotion option for filgotinib with collaboration partner $gild  in eight european countries URL"}
{"text": "$glpg exercises co-promotion option for filgotinib with collaboration partner $gild  in eight european countries URL"}
{"text": "don't miss our next free option trade.  sign up for our daily free trades at URL $nvda $tsla $gs $gild $mu $googl $fb"}
{"text": "cost to protect downside 4 the next 30 days. $vrx $dis $nflx $labu $swn $gild $iwm $orcl $foxa $uvxy $juno URL $orcl"}
{"text": "state of wisconsin investment board has raised its gilead sciences $gild position URL"}
{"text": "$juno $44.00 long jcar017 $nvs $gild URL"}
{"text": "miss any of our #ash2017 stories? we've got you covered. URL $abbv $argx $blue $bmrn $gild $jnj\u00a1\u00ad URL"}
{"text": "rt AT_USER cancer patients with little time left waiting for potential breakthrough drug from gilead (yescarta): \"no medicare cov\u00a1\u00ad"}
{"text": "rt AT_USER this is a very good story, validates concerns of many investors about pace of car-t launch and complexities of reimburs\u00a1\u00ad"}
{"text": "took the $gild day trade off flat  no cushion will revisit"}
{"text": "$gild -7407.lod"}
{"text": "#options #maxpain chart for $gild. free options app URL URL"}
{"text": "not sure what to do with $gild? explore our #fundamental pros and cons.  URL"}
{"text": "the toci trials for car t cell induced crs and hlh are both on-going, and this is what fda has to say about its app\u00a1\u00ad URL"}
{"text": "$gild 7414.stop.bottomed-out"}
{"text": "rt AT_USER are you #investing or #trading #biotechstocks? check the latest analysis on $biib $amgn $gild &amp; $celg bargain #stocks .\u00a1\u00ad"}
{"text": "are you #investing or #trading #biotechstocks? check the latest analysis on $biib $amgn $gild &amp; $celg bargain\u00a1\u00ad URL"}
{"text": "$gild #options oi chart. free stocks app URL URL"}
{"text": "months after approval, breakthrough cancer drug given to just five patients $nvs $kite $gild URL URL"}
{"text": "they waited too long to start dealing with reimbursement issues.  $gild URL"}
{"text": "$gild will be quick to raise stop to b/e area once green as a day trade for now and have no interest in a negative trade today"}
{"text": "put on an intraday bounce trade $gild day trade for now swing plan ready if enough cushion at the close   using 5-15 minute chart."}
{"text": "recent $gild technical alerts: crossed above 50 dma plus 7 more alerts... URL"}
{"text": "rt AT_USER $gild likely to miss yescarta estimates of early sales URL $kite $juno $nvs"}
{"text": "$gild 1/19/18 80 calls swept - wish you luck"}
{"text": "i am guessing that the judges will allow the manufacturing of yescarta, but i think what will happen is that $gild\u00a1\u00ad URL"}
{"text": "i do think we will see abnormally high royalties to $juno.  that's my prediction regarding both the ipr appeal and\u00a1\u00ad URL"}
{"text": "don't miss our next free option trade.  sign up for our daily free trades at URL $nvda $tsla $gs $gild $amd $googl $fb"}
{"text": "$gild is lucky.  the backlog of patients is the only thing that is going to save it from being stopped from manufac\u00a1\u00ad URL"}
{"text": "$gild looks like i\u00a1\u00afll be buying back in again soon enough if this continues."}
{"text": "tnb financial has lowered its gilead sciences com $gild position URL"}
{"text": "rt AT_USER as author of \"cheson\"&amp; updates,drc's lead of $tgtx tr says a lot re program,&amp; need of alt. txs,doesn't it! $ibb $xbi $abbv $\u00a1\u00ad"}
{"text": "as author of \"cheson\"&amp; updates,drc's lead of $tgtx tr says a lot re program,&amp; need of alt. txs,doesn't it! $ibb\u00a1\u00ad URL"}
{"text": "rt AT_USER been opining on this for almost 2 yrs now. patient access, patient access, patient access. $gild $juno $nvs URL"}
{"text": "$gild what a pathetic company..."}
{"text": "biotechs need to hold this support: $ibb $gild $regn $celg $biib $vrtx --&gt;&gt; URL URL"}
{"text": "the #biotech industry has some bargain #stocks - get the low down on $biib $amgn $gild and $celg in this great arti\u00a1\u00ad URL"}
{"text": "2/2 $juno vs $kite $gild deaths from crs neurotox:  $juno 0 pts - none - $kite 4pt died and 5th reported in data up\u00a1\u00ad URL"}
{"text": "rt AT_USER cancer patients with little time left waiting for potential breakthrough drug from gilead (yescarta): \"no medicare cov\u00a1\u00ad"}
{"text": "rt AT_USER cancer patients with little time left waiting for potential breakthrough drug from gilead (yescarta): \"no medicare cov\u00a1\u00ad"}
{"text": "AT_USER i\u00a1\u00afm assuming md anderson and stanford have a handshake agreement with $gild about the patients they\u00a1\u00afve\u00a1\u00ad URL"}
{"text": "cancer patients with little time left waiting for potential breakthrough drug from gilead (yescarta): \"no medicare\u00a1\u00ad URL"}
{"text": "#eurobiotech report\u00a1\u00aagilead-hookipa, erytech fail, #nash #startup, vernalis-daiichi and #amrc #biotech #pharma\u00a1\u00ad URL"}
{"text": "$juno vs $kite $gild neuro toxicity comps: $kite 108pts $juno 91pts evaluble for safety. results:  kite 87% of 108\u00a1\u00ad URL"}
{"text": "rt AT_USER been opining on this for almost 2 yrs now. patient access, patient access, patient access. $gild $juno $nvs URL"}
{"text": "rt AT_USER this is a very good story, validates concerns of many investors about pace of car-t launch and complexities of reimburs\u00a1\u00ad"}
{"text": "$gild hammered."}
{"text": "$juno patients had much higher tumor burden than $kite $gild patients but have so far better efficacy and much bett\u00a1\u00ad URL"}
{"text": "$gild the pos, is she making a secondary today ?!"}
{"text": "rt AT_USER this is a very good story, validates concerns of many investors about pace of car-t launch and complexities of reimburs\u00a1\u00ad"}
{"text": "maxim group analysts give gilead sciences $gild a $94.00 price target URL"}
{"text": "maxim group analysts give gilead sciences $gild a $94.00 price target URL"}
{"text": "the top 10 prospective #blockbuster drug launches slated for 2018 \u00a1\u00aa evaluate - #hiv #diabetes #oncology #ms\u00a1\u00ad URL"}
{"text": "maxim group analysts give gilead sciences $gild a $94.00 price target URL"}
{"text": "don't miss our next free option trade.  sign up for our daily free trades at URL $nvda $tsla $gs $gild $ibb $googl $fb"}
{"text": "rt AT_USER this is a very good story, validates concerns of many investors about pace of car-t launch and complexities of reimburs\u00a1\u00ad"}
{"text": "rt AT_USER this is a very good story, validates concerns of many investors about pace of car-t launch and complexities of reimburs\u00a1\u00ad"}
{"text": "rt AT_USER perils of first: $gild's yescarta can save the lives of lymphoma patients. we talked to everyone authorized to give it. only\u00a1\u00ad"}
{"text": "gilead sciences $gild market value declined while beech hill advisors has trimmed position ..."}
{"text": "rt AT_USER this is a very good story, validates concerns of many investors about pace of car-t launch and complexities of reimburs\u00a1\u00ad"}
{"text": "rt AT_USER this is a very good story, validates concerns of many investors about pace of car-t launch and complexities of reimburs\u00a1\u00ad"}
{"text": "got bullish this summer with large volume, reference 2014 for same setup.. recent pullback to 200 day/50 week was e\u00a1\u00ad URL"}
{"text": "sandy spring bank has decreased by $377,860 its gilead sciences  $gild position URL"}
{"text": "rt AT_USER this is a very good story, validates concerns of many investors about pace of car-t launch and complexities of reimburs\u00a1\u00ad"}
{"text": "gilead sciences $call $gild valuation declined while peak asset management trimmed its position ..."}
{"text": "rt AT_USER perils of first: $gild's yescarta can save the lives of lymphoma patients. we talked to everyone authorized to give it. only\u00a1\u00ad"}
